Showing results (11-20 of 60) with videos related to
Sort By:
Pageof 6
Biotechnology Letters|September 2, 2017
Novel one-pot ATP regeneration system based on three-enzyme cascade for industrial CTP productionJunzhi Wang, Cheng Zheng, Tianyi Zhang, et al.Investigational New Drugs|July 5, 2014
Effects of the combination of TRC105 and bevacizumab on endothelial cell biologyYingmiao Liu, Hongyu Tian, Gerard C Blobe, et al.Microbial Cell Factories|September 14, 2011
Metabolic engineering of the L-phenylalanine pathway in Escherichia coli for the production of S- or R-mandelic acidZhoutong Sun, Yuanyuan Ning, Lixia Liu, et al.Journal of Neuroscience Methods|July 8, 2008
Adeno-associated virus-mediated ILK gene silencing in the rat NAc coreQiang Chen, Xueying Xiong, Tong H Lee, et al.Anti-Cancer Drugs|January 1, 2013
Dual inhibition of αV integrins and Src kinase activity as a combination therapy strategy for colorectal cancerJingquan Jia, Alex Starodub, Ian Cushman, et al.Biochemical and Biophysical Research Communications|June 15, 2007
NF-kappaB inhibition by an adenovirus expressed aptamer sensitizes TNFalpha-induced apoptosisJing Mi, Xiuwu Zhang, Yingmiao Liu, et al.Nature Chemical Biology|December 1, 2009
In vivo selection of tumor-targeting RNA motifsJing Mi, Yingmiao Liu, Zahid N Rabbani, et al.Biological Chemistry|December 2, 2008
Aptamers selected against the unglycosylated EGFRvIII ectodomain and delivered intracellularly reduce membrane-bound EGFRvIII and induce apoptosisYingmiao Liu, Chien-Tsun Kuan, Jing Mi, et al.British Journal of Clinical Pharmacology|April 19, 2022
Plasma levels of VEGF-A and VCAM-1 as predictors of drug-induced hypertension in patients treated with VEGF pathway inhibitorsJulia C F Quintanilha, Kelli Hammond, Yingmiao Liu, et al.Applied Microbiology and Biotechnology|October 15, 2016
Efficient multi-enzyme-catalyzed CDP-choline production driven by an ATP donor moduleYingmiao Liu, Junzhi Wang, Chongmao Xu, et al.Pageof 6